Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension

Background: To improve clinical outcome, patients with inoperable and residual chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with riociguat. The aim of this study is to explore long-term outcomes and to compare our ‘real world’ data with previous research. Methods: We included...

Full description

Bibliographic Details
Main Authors: M.C.J. van Thor, L. ten Klooster, R.J. Snijder, M.C. Post, J.J. Mager
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906719300144